XML 33 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Antidilutive Securities Excluded and Imapirment charges          
Revenue percentage     100.00% 100.00%  
Research and development costs $ 78,371 $ 177,885 $ 172,760 $ 282,339  
Fair value of notes $ (200,000)   $ (200,000)    
Warrants exercisable shares 4,175,000   4,175,000   4,275,000
Weighted average common shares outstanding 31,750,106 31,750,106 31,750,106 31,750,106